Trials / Completed
CompletedNCT04787445
Effects of Pulmonary Hypertension Therapy in Atypical Pulmonary Arterial Hypertension
Effects of Pulmonary Hypertension Therapy in Atypical Pulmonary Arterial Hypertension: An Exercise Hemodynamic Study (TAPH Study)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 19 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to characterize the clinical and hemodynamic response of Pulmonary Arterial Hypertension (PAH) therapy in patients with atypical PAH and risk factors for left heart disease.
Detailed description
This is an observational prospective study to better understand the clinical impact of Pulmonary Arterial Hypertension (PAH) specific therapy in patients with atypical PAH among those with risk factors for left heart disease The study involves detailed baseline clinical evaluation prior to initiation of PAH therapy, followed by repeat clinical assessment after 6 months of medical therapy
Conditions
Timeline
- Start date
- 2021-03-11
- Primary completion
- 2023-11-21
- Completion
- 2023-11-21
- First posted
- 2021-03-08
- Last updated
- 2024-03-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04787445. Inclusion in this directory is not an endorsement.